tiprankstipranks
Trending News
More News >
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market

Compare Belite Bio, Inc. ADR (BLTE) vs. Competitors

Compare
51 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Belite Bio, Inc. ADR
$154.93
$5.41B
-80.70
150.01%
6 Buy
0 Hold
0 Sell
Strong Buy
Denali Therapeutics
$18.16
$2.63B
-5.79
-16.65%
11 Buy
0 Hold
0 Sell
Strong Buy
Kiniksa Pharmaceuticals
$42.00
$3.18B
93.67
114.29%
6 Buy
0 Hold
0 Sell
Strong Buy
Beam Therapeutics
$27.98
$2.84B
-6.31
10.72%
11 Buy
2 Hold
0 Sell
Strong Buy
Harmony Biosciences Holdings
$38.13
$2.20B
12.01
11.95%
5 Buy
0 Hold
1 Sell
Moderate Buy
Centessa Pharmaceuticals
$25.33
$3.40B
-13.92
46.76%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BLTE
Belite Bio, Inc. ADR
154.93
92.96
150.01%
DNLI
Denali Therapeutics
16.87
-3.37
-16.65%
KNSA
Kiniksa Pharmaceuticals
42.00
22.40
114.29%
BEAM
Beam Therapeutics
27.98
2.71
10.72%
HRMY
Harmony Biosciences Holdings
38.13
4.07
11.95%
CNTA
Centessa Pharmaceuticals
25.33
8.98
54.92%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts